SLC2A2 and type 1 diabetes mellitus: Notably, subject HU2003 had been diagnosed with T1D for 58 years since age 1 year old and yet increased the percentages of GLUT2+CD45RO+ PB-IPC from 0% at baseline to 72.09% at the sixth month and to 89.89% at the twelfth month follow-up post the treatment with stem cell educator therapy (Figure 3B).